HHS funds vaccine candidates for Marburg, Sudan ebolavirus
The Department of Health and Human Services yesterday awarded $20.5 million to develop vaccine candidates for Marburg virus and Sudan ebolavirus, which are in the same family of viruses as the Ebola virus outbreak in the Democratic Republic of the Congo. The last outbreaks of Marburg virus and Sudan ebolavirus were in Uganda, in 2017 and 2012, respectively. The Sabin Vaccine Institute will conduct nonclinical studies and complete manufacturing activities to advance the development of the vaccine candidates under a contract with HHS’s Biomedical Advanced Research and Development Authority. BARDA also is helping to develop and procure vaccines, therapeutics and diagnostics for the Ebola strain circulating in the Congo.
Related News Articles
Headline
The Cell and Gene Therapy Access Model, which seeks to increase access to treatments for Medicaid enrollees with rare and severe diseases, will initially focus…
Headline
The Centers for Disease Control and Prevention is following up on a previous alert of an outbreak of suspected fungal meningitis in Texas, which is now…
Headline
The U.S. Preventive Services Task Force yesterday released for public comment through June 5 a draft recommendation that all women get screened for breast…
Headline
In the latest podcast in AHA’s Advancing Health podcast series on leading initiatives to transform care and advance equity, leaders from Montage Health and…
Headline
As a precaution in response to the recent Ebola outbreak in Uganda, the Centers for Disease Control and Prevention and Department of Homeland Security Customs…
Headline
The Centers for Disease Control and Prevention today issued an advisory to remind U.S. clinicians of best practices for evaluating patients for suspected Ebola…